@inproceedings{inproceedings, title  = {{2510 3-year follow-up of chemotherapy following radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients (Pts) with symptomatic bone metastases (Mets) from ALSYMPCA}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2015}},

 month = {{9}},

 author = {{Sartor O and Coleman RE and Nilsson S and Vogelzang NJ and Staudacher K and Thuresson M and Parker C}},

 doi = {{10.1016/s0959-8049(15)30047-2}},

 volume = {{51}},

 journal = {{European Journal of Cancer}},

 pages = {{S477-S477}},

 note = {{Accessed on 2025/10/10}}}